Cited by 8Genomics and Rare DiseasesGenetics and Neurodevelopmental DisordersMetabolism and Genetic Disorders

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Broadening the phenotypic and molecular spectrum of FINCA syndrome: Biallelic NHLRC2 variants in 15 novel individuals

Open access

Published version of a preprint

Abstract

FINCA syndrome [MIM: 618278] is an autosomal recessive multisystem disorder characterized by fi brosis, n eurodegeneration and c erebral a ngiomatosis. To date, 13 patients from nine families with biallelic NHLRC2 variants have been published. In all of them, the recurrent missense variant p.(Asp148Tyr) was detected on at least one allele. Common manifestations included lung or muscle fibrosis, respiratory distress, developmental delay, neuromuscular symptoms and seizures often followed by early death due to rapid disease progression. Here, we present 15 individuals from 12 families with an overlapping phenotype associated with nine novel NHLRC2 variants identified by exome analysis. All patients described here presented with moderate to severe global developmental delay and variable disease progression. Seizures, truncal hypotonia and movement disorders were frequently observed. Notably, we also present the first eight cases in which the recurrent p.(Asp148Tyr) variant was not detected in either homozygous or compound heterozygous state. We cloned and expressed all novel and most previously published non-truncating variants in HEK293-cells. From the results of these functional studies, we propose a potential genotype-phenotype correlation, with a greater reduction in protein expression being associated with a more severe phenotype. Taken together, our findings broaden the known phenotypic and molecular spectrum and emphasize that NHLRC2 -related disease should be considered in patients presenting with intellectual disability, movement disorders, neuroregression and epilepsy with or without pulmonary involvement.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41431-023-01382-0

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 18

  1. Biterova E, Ignatyev A, Uusimaa J, Hinttala R, Ruddock LW. Structural analysis of human NHLRC2, mutations of which are associated with FINCA disease. PLoS One. 2018;13:e0202391. · DOI
  2. Nishi K, Iwaihara Y, Tsunoda T, Doi K, Sakata T, Shirasawa S, et al. ROS-induced cleavage of NHLRC2 by caspase-8 leads to apoptotic cell death in the HCT116 human colon cancer cell line. Cell Death Dis. 2017;8:3218. · DOI
  3. Hiltunen AE, Vuolteenaho R, Ronkainen VP, Miinalainen I, Uusimaa J, Lehtonen S, et al. Nhlrc2 is crucial during mouse gastrulation. Genesis 2022;60:e23470. · DOI
  4. Uusimaa J, Kaarteenaho R, Paakkola T, Tuominen H, Karjalainen MK, Nadaf J, et al. NHLRC2 variants identified in patients with fibrosis, neurodegeneration, and cerebral angiomatosis (FINCA): characterisation of a novel cerebropulmonary disease. Acta Neuropathol. 2018;135:727–42. · DOI
  5. Brodsky NN, Boyarchuk O, Kovalchuk T, Hariyan T, Rice A, Ji W, et al. Novel compound heterozygous variants in NHLRC2 in a patient with FINCA syndrome. J Hum Genet. 2020;65:911–5. · DOI
  6. Rapp CK, Van Dijck I, Laugwitz L, Boon M, Briassoulis G, Ilia S, et al. Expanding the phenotypic spectrum of FINCA (fibrosis, neurodegeneration, and cerebral angiomatosis) syndrome beyond infancy. Clin Genet. 2021;100:453–61. · DOI
  7. Badura-Stronka M, Śmigiel R, Rutkowska K, Szymańska K, Hirschfeld AS, Monkiewicz M, et al. FINCA syndrome-Defining neurobehavioral phenotype in survivors into late childhood. Mol Genet Genom Med. 2022;10:e1899. · DOI
  8. Rillig F, Grüters A, Bäumer T, Hoffmann GF, Choukair D, Berner R, et al. The Interdisciplinary diagnosis of rare diseases-results of the translate-NAMSE Project. Dtsch Arztebl Int [Internet]. 2022 Jul;(Forthcoming). Available from: https://doi.org/10.3238/arztebl.m2022.0219 · DOI
  9. Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36:928–30. · DOI · Paper page
  10. Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 2014;42:D980–5. · DOI · Paper page
  11. Philippakis AA, Azzariti DR, Beltran S, Brookes AJ, Brownstein CA, Brudno M, et al. The Matchmaker Exchange: a platform for rare disease gene discovery. Hum Mutat. 2015;36:915–21. · DOI
  12. Neitzel H A. routine method for the establishment of permanent growing lymphoblastoid cell lines [Internet]. Vol. 73, Human Genetics. 1986. p. 320–6. Available from: https://doi.org/10.1007/bf00279094 · DOI
  13. Gainza P, Sverrisson F, Monti F, Rodolà E, Boscaini D, Bronstein MM, et al. Deciphering interaction fingerprints from protein molecular surfaces using geometric deep learning. Nat Methods. 2020;17:184–92. · DOI
  14. Steinhaus R, Boschann F, Vogel M, Fischer-Zirnsak B, Seelow D. AutozygosityMapper: Identification of disease-mutations in consanguineous families. Nucleic Acids Res [Internet]. 2022 Apr; Available from: https://doi.org/10.1093/nar/gkac280 · DOI
  15. Vogt G, Verheyen S, Schwartzmann S, Ehmke N, Potratz C, Schwerin-Nagel A, et al. Biallelic truncating variants in ATP9A cause a novel neurodevelopmental disorder involving postnatal microcephaly and failure to thrive. J Med Genet [Internet]. 2021 Jun; Available from: https://doi.org/10.1136/jmedgenet-2021-107843 · DOI
  16. Perez-Garcia V, Fineberg E, Wilson R, Murray A, Mazzeo CI, Tudor C, et al. Placentation defects are highly prevalent in embryonic lethal mouse mutants. Nature 2018;555:463–8. · DOI
  17. Steinhaus R, Proft S, Schuelke M, Cooper DN, Schwarz JM, Seelow D. MutationTaster2021. Nucleic Acids Res. 2021;49:W446–51. · DOI
  18. Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, et al. AlphaFold Protein Structure Database: Massively expanding the structural coverage of protein-sequence space with high-accuracy models [Internet]. Vol. 50, Nucleic Acids Research. 2022. p. D439–44. Available from: https://doi.org/10.1093/nar/gkab1061 · DOI · Paper page

Metadata

Authors
Sczakiel, H. L., Zhao, M., Wollert-Wulf, B., Danyel, M., Ehmke, N., Stoltenburg, C., Damseh, N., Al-Ashhab, M., Balci, T. B., Osmond, M., Andrade, A., Schallner, J., Porrmann, J., McDonald, K., Liao, M., Oppermann, H., Platzer, K., Dierksen, N., Mojarrad, M., Eslahi, A., Bakaeean, B., Calame, D. G., Lupski, J. R., Firoozfar, Z., Seyedhassani, S. M., Mohammadi, S. A., Anwaar, N., Rahman, F., Seelow, D., Janz, M., Horn, D., Maroofian, R., & Boschann, F.
Affiliations
  • Humboldt-Universität zu Berlin (DE)
  • Al-Quds University (PS)
  • University of Ottawa (CA)
  • Western University (CA)
  • University Hospital Carl Gustav Carus (DE)
  • Technische Universität Dresden (DE)
  • University of Mississippi Medical Center (US)
  • University Hospital Leipzig (DE)
  • Evangelisches Krankenhaus Oberhausen (DE)
  • Mashhad University of Medical Sciences (IR)
  • Islamic Azad University, Tehran (IR)
  • Baylor College of Medicine (US)
  • University of Child Health Sciences (PK)
  • Max Delbrück Center (DE)
  • UCL Queen Square Institute of Neurology (GB)
Corresponding author
Boschann, Felix
Venue
European Journal of Human Genetics
Published
2023-05-15
Volume
31
Issue
8
Pages
905-917
ISSN
  • 1018-4813 (ISSN-L)
  • 1476-5438
OpenAlex
W4376641890
Cited by
8
References
4
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2023: 1
FWCI
1.33
Type
journal article
Language
en
Open access
Locations
  • European Journal of Human Genetics (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion, other-oa)
  • UCL Discovery (University College London) (submittedVersion, cc-by)
  • Refubium (Universitätsbibliothek der Freien Universität Berlin) (submittedVersion, cc-by)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
  • Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver (cc-by)
Funders
  • Genome Canada (OGI‐147)
  • Ontario Genomics
  • Ontario Genomics Institute (OGI‐147)
  • Genome British Columbia
  • Genome Alberta
  • Berlin Institute of Health
  • Canadian Institutes of Health Research (OGI-147)
  • National Human Genome Research Institute (UM1HG006542, U01HG011758)
  • National Institute of General Medical Sciences (T32GM007526)
  • National Institute of Neurological Disorders and Stroke (R35NS105078)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
biallelic variants, novel variants, genotype-phenotype correlation, global developmental delay, intellectual disability, seizures, movement disorders, neurodegeneration, pulmonary fibrosis, compound heterozygosity, protein expression, autosomal recessive disorder
MeSH terms
Fibrosis, Humans, Intellectual Disability, Movement Disorders, Phenotype, Seizures, Syndrome, Disease Progression, Intracellular Signaling Peptides and Proteins, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review